Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma ; volume:11 ; number:1 ; day:8 ; month:2 ; year:2011 ; pages:1-7 ; date:12.2011
BMC cancer ; 11, Heft 1 (8.2.2011), 1-7, 12.2011

Creator: Deshpande, Vikram

Contributor: Nduaguba, Afamefuna
Zimmerman, Stephanie M.
Kehoe, Sarah M.
MacConaill, Laura E.
Lauwers, Gregory Y.
Ferrone, Cristina
Bardeesy, Nabeel
Zhu, Andrew X.
Hezel, Aram F.
SpringerLink (Online service)

DOI: 10.1186/1471-2407-11-60

URN: urn:nbn:de:1111-2016030361964

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Deshpande, Vikram
Nduaguba, Afamefuna
Zimmerman, Stephanie M.
Kehoe, Sarah M.
MacConaill, Laura E.
Lauwers, Gregory Y.
Ferrone, Cristina
Bardeesy, Nabeel
Zhu, Andrew X.
Hezel, Aram F.
SpringerLink (Online service)

Other Objects (12)

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

Mutational profiling of kinases in glioblastoma

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

Mutational profiling of kinases in glioblastoma

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

Mutational profiling of kinases in glioblastoma

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

$Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas$

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

Mutational profiling of kinases in glioblastoma

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

Mutational profiling of kinases in glioblastoma

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

PIK3CA-mutations in breast cancer

PIK3CA mutations in endocrine-resistant breast cancer

Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

Mutational profiling of kinases in glioblastoma

Frequency and spectrum of PIK3CA somatic mutations in breast cancer

Proteomic alterations in extracellular vesicles induced by oncogenic PIK3CA mutations

The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

Related objects

Reset password